Subsequent studies investigating the use of CD8+ T cells molecularly engineered to express defined HIV-specific TCR (TCR T cells) demonstrated that TCR T cells specific for the immunodominant Gag-derived epitope, SL9, potently inhibited HIV infection both in vitro and in vivo [210,211]. Here, CD8A is linked to HIV infectious disease.